Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -3.07% | 11.69% | -208.16% | 29.19% | |
| Total Depreciation and Amortization | -253.05% | 329.41% | -7.79% | 161.14% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 0.67% | -33.29% | 242.74% | -41.83% | |
| Change in Net Operating Assets | -73.13% | -37.40% | 372.63% | 19.21% | |
| Cash from Operations | -144.03% | -55.18% | 1,267.35% | 22.30% | |
| Capital Expenditure | 107.01% | 48.61% | 37.20% | 14.06% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 68.40% | 37.67% | -302.34% | -294.72% | |
| Cash from Investing | 70.61% | 37.92% | -207.07% | -250.11% | |
| Total Debt Issued | 250.00% | -69.23% | -- | -- | |
| Total Debt Repaid | -29.02% | -31.51% | -19.18% | -18.74% | |
| Issuance of Common Stock | -100.00% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.67% | 96.01% | 93.79% | -18.01% | |
| Cash from Financing | 236.01% | -71.22% | 202.21% | 274.58% | |
| Foreign Exchange rate Adjustments | 111.96% | 124.07% | 41.77% | -64.29% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 63.17% | -449.02% | 190.54% | 68.91% | |